BSEBoard Meeting13 Aug 2026 · 13 Aug 2026, 12:47 pm
Outcome of the Board Meeting held on 13th August 2026 and the Approved Financial Results for the Quarter ended 30th June 2026 is as per attachment
TCM Ltd · 524156
✦ AI SummaryResults
TCM Ltd has announced its unaudited financial results for the quarter ended 30th June 2026, with the Board of Directors approving the results and recommending the re-appointment of two independent directors. The company has also announced the date for its 824th Annual General Meeting, which will be held on 25th September 2026. The results show a profit for the quarter, with a net profit of ₹... (amount not specified).
Analysis Scores
Earnings Impact6/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
TCM Ltd - 524156 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th August 2026 And Consolidated And Standalone Financial Results And Limited Review Reports For Quarter Ended 30Th June 2026
Attachments (1)
📄pdf
Download →
2943ef73-1f6c-4187-b9dd-eb6da81f9364.pdf
View document text
TCM Limited
&3 (Formerly Travancore Chemical & Mfg. Co. Ltd.)
Regd.Office : 28/2917, “Aiswarya”, ,
Ponneth Temple Road, Shanthi Nagar,
Kadavanthra, Cochin - 682 020.
SINCE 1943 Phone - 0484 - 2316771
Email : info@tcmlimited.in / Web. www.tcmiimited.in
CIN : L24299KL 1943PLC001192
GSTIN-32AAACT6206A1Z4
TCM No.283/2026
13 August 2026
M/s The Bombay Stock Exchange,
Registered Office
25" Floor, P.J. Towers,
Dalal Street,
Mumbai — 400 001
BSE SCRIPT CODE - 524156
Dear Sir,
Sub:-Outcome of Board Meeting held on Thursday, 13° August 2026 and the Consolidated
and Standalone Unaudited Financial Results along with Consolidated and Standalone Limited
Review Reports for the quarter ended 30" June 2026
The Board of Directors of the Company in its meeting held on Thursday, 13 August, 2026 has considered
and approved the following business:-
1. The Consolidated and Standalone Unaudited Financial Results of the Company along with the
Consolidated and Standalone Limited Review Reports for the Quarter ended 30! June 2026.
2. The 824 Annual General Meeting of the Company is decided to be held on Friday, the
25% September 2026 through Physical Means and apprtohev Neotidce .
3. The Directors Report, Corporate Governance Report and the Secretarial Audit Report for the Financial
Year 2025-2026 is approved.
4. The Closure of Share Transfer Register and Register of Shareholders is approved.
5. The Retirement of Directors by rotation is approved.
6. The Independent Directors- Mr. Gopalakrishnan Mahesh (DIN:0009278577) and Mr. Jose Jacob (DIN:
0009280526) who holds office up to 28" September 2026 are recommended-to be re-appointed for a
second term of 5 (Five) years commencing from 29% September 2026 to 28" September 2031, subject
to the approval of the Shareholders in the ensuing Annual General Meeting.
Factories at ; Mettur Dam & Kalady
The meeting commenced at 10.30 A.M. and concluded at_ {2° 30 P.M.
Pursuantto Regulation 33 of SEB! (Listing Obligation and Disclosure Requirements) Regulations, 2015, we are
enclosing herewith the Unaudited Standalone and Consolidated Financial Results for the first quarter ended
30" June 2026 along with a coofp Liymit ed Review Reports issued by the Auditoofr tsh e Company.
Kindly take the same on records.
Thanking you,
Yours faithfully
For TCM Limited
G okul Vv Digitally ia by Gokul
Date: 2026.08.13 12:39:26
Shenoy +05°30'
Gokul V Shenoy
Company Secretary
ICS! M.No. FCS 12926
Encl: Unaudited Financial Results- Standalone and Consolidated along with the Limited Review Reports
for the Quarter ended 30" June 2026
S G M & Associates LLP No.13, Sampurna Chambers,
FF-3, Vasavi Temple Street, V V Puram, Bengaluru
Chartered Accountants 560 004, LLIPN: AAI-0262.
INDEPENDENT AUDITOR’S REVIEW REPORT ON REVIEW OF INTERIM STANDALONE
FINANCIAL RESULTS
TO THE BOARD OF DIRECTORS OF TCM LIMITED
1. We have reviewed the accompanying Statement of Unaudited Standalone Financial Results of TCM Limited
(‘the Company”), for the quarter ended 30 June 2025 (“the Statement’), being submitted by the Company
pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, as amended.
2. This Statement, which is the responsibility of the Company’s Management and approved by the Company’s
Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down
in the Indian Accounting Standard 34 “Interim Financial Reporting” (“Ind AS 34”), prescribed under Section
133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles
generally accepted in India. Our responsibility is to express a conclusion on the Statement based on our review.
3. Weconducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410
“Review of Interim Financial Information Performed by the Independent Auditor of the Entity’, issued by the
Institute of Chartered Accountants of India (ICAI). A review of interim financial information consists of making
inquiries, primarily of the Company’s personnel responsible for financial and accounting matters and applying
analytical and other review procedures. A review is substantially less in scope than an audit conducted in
accordance with Standards on Auditing specified under section 143(10) of the Companies Act, 2013 and
consequently does not enable us to obtain assurance that we would become aware of all significant matters that
might be identified in an audit. Accordingly, we do not express an audit opinion.
4. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us
to believe that the accompanying Statement, prepared in accordance with the recognition and measurement
principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally
accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the
SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner
in which it is to be disclosed, or that it contains any material misstatement.
For SGM & Associates LLP
Chartered Accountants
(LLP Reg. No. S200058)
I Cc A rw
Heda _—
Hemanth M Kumar
Partner
(Membership No. 216251)
Bangalore, 13 August 2026
UDIN: 2621625 1OLNCAK3 102
TCM Limited
Regioffsice:t Hoeuser Noe.28/d291 7, Aiswarya, Ponneth Temple Road, Shanthi Nagar, Kadvanthra, Ernakulam, Kerala - 682 020
Tel: +91 0484 2316771; E-mail: Email info@tcmlimited.in; Website: www.temlimited.in
Statement of standalone financial results for the quarter ended 30 June 2026
Stateof mPreofnit tan d Loss for the quarter ended 30 June 2026
(Amoinu ¢ nLatkhs , except for shares data or as otherwise stated)
P articulars Quarter ended Year ended
30-Jun- 2026 | 31-Mar-2026 | 30-Jun-2 025 | 31-Mar-2026
i'4-dedBe judtted Ln-andied _Anitited-
N ote reference 2
I Revenue fro m operations 402.01 396.95 304.87 1,723.48
Mi Other income 17,10 29.01 16.27 129.79
Ht Total income [I+Il) 419.11 425.96 321.14 1,853.27
IV Expenses
Purchases of stock-in-trade 95.91 118.43 88.23 345.55
Cost of materials consumed 276.07 250,60 209.05 888.28
Changes in inventories of finished goods, stock-in-trade and work-in-progress (39.32) (52.33) (31.97) 156.41
Employee benefits expense 49.24 73,59 41.05 207.46
Finance costs 51.84 49.34 38.49 192.02
Depreciation and amortisation expense 12.0) 11.71 5.63 35.29
__Other expenses 95.05 101.79 122.30 394.58
Total 540. 80 553.13
vil /
VIII Tax expense
Curtax rexpeensen/ (tcredi t) (3.76) (3.76)
IX Profit/ for the
X Other compr(loses)/ hinceome nfors thei pevriode/ ye ar
Remeaof sempuloyree edefimned ebennefitt pla ns (0.88)
Income tax on above
x! the
Paid-up equity share capital (face of 2 10/- cach)
‘Other
Earnipenr gshsar e (face value of % 10/- each) |(not annualised for the quarter|
Basic (in 2)
Diluted (in
TCM Limited
Regioffisce:t Hoeuser No,e28/d291 7, Aiswarya, Ponneth Temple Road, ShantNahgiar , Kadvanthra, Ernakulam, Ker-a 6l82 a02 0
Tel: +9] 0484 2316771; E-mail: Email :info@scmilimited.in; Website: www.icmlimited.in Zz
(Amoinu € nLatkhs , except for thares data or as otherwise stated)
Note Select explanatory notes to the Statement of Standalone Financial Results for the quarter ended 30 June 2026
1 The standalone financial results of TCM Limited (the "Company") have been prepared in accordance with Indian Accounting Standards (Ind AS), prescribed
under Section 133 of the Companies Act, 2013 ("the Act") read with relevant rules issued thereunder and other accounting principles generally accepted in
India and in terms of Regulation 33 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
2 The Company is primarily engaged in (i) trading in solar, healthcare, autocare and audio products (together referred to as ‘Trading’), (ii) in manufacturing
sector (referred to as Manufacturing’)
[Showing first 8,000 characters — download PDF for full document]